$500 Billion in New U.S. Biopharmaceutical Investment
PhRMA member companies are investing to fuel innovation and bring new jobs to communities across America. Our new investments will deliver a $1.2 trillion boost to the U.S. economy.
Where’s the Drug Dollar Going?
Our current system is inefficient and costs Americans more than it should due to unnecessary bureaucracy. In fact, half of every dollar goes to someone who did not make the medicine.
North Carolina’s Research Triangle Park is a Powerhouse for Biopharma Innovation and Economic Growth
Decades of investment in North Carolina’s biopharmaceutical industry has spurred the state’s economy, workforce development and community engagement.
Gilead Boosts U.S. Manufacturing Capacity to Advance Next-Generation Biologics
Gilead’s new Bay Area facility is supporting the American workforce while underscoring its commitment to strengthening U.S. biopharmaceutical leadership.
Lilly invests in Virginia to expand U.S. manufacturing and advance next-generation medicines
Lilly’s new state-of-the-art facility in Virginia will strengthen America’s biopharmaceutical manufacturing capabilities and create economic opportunities for workers and communities across the state.
A New Era of Biopharmaceutical Innovation
The biopharmaceutical industry is on the brink of unprecedented breakthroughs, with the potential to revolutionize health care, reduce the burden of disease and create a healthier future for all.
Our Work in Action
To maintain America’s global leadership, we need to support the next generation of innovation in medicine.
